Insulet Corporation
Could not find a ticker for this position, may be a filing error
A maker of the Omnipod, a tubeless, wearable insulin pump worn on the skin that lets people with diabetes manage their insulin without daily injections or tubing. The company was founded in 2000 after co-founder John Brooks' young son was diagnosed with type 1 diabetes, and its name blends "insulin" and "let." Legend has it Brooks first sketched the device's design on a napkin aboard an airplane.
Convertible Senior Note 1.375% due 11/15/2024
Sold 511.1K
Sold 1.01M
Granted 8.0K · Sold 807.4K
Granted 267.7K · Bought 125.0K
Granted 1.11M · Sold 792.5K
Granted 241.4K · Sold 45.5K
Granted 301.0K · Sold 150.0K
Granted 431.8K · Bought 8.0K · Sold 282.8K
Granted 477.0K · Sold 246.9K
Sold 31.0K
Granted 80.0K · Sold 80.0K
Granted 10.7K · Bought 20.0K
Granted 285.8K · Sold 192.3K
Granted 77.9K · Bought 12.6K · Sold 10.8K
Granted 36.6K · Bought 8.0K · Sold 4.0K
Granted 89.1K · Bought 5.5K
Granted 145.8K · Bought 9.1K · Sold 60.0K
Granted 75.8K · Sold 1.4K
Granted 47.3K · Bought 3.7K
Granted 14.6K · Bought 5.3K
Granted 72.0K · Sold 51.1K
Granted 17.8K
Granted 44.8K · Bought 3.5K · Sold 15.3K
Granted 14.0K · Sold 8.3K
Granted 281.0K · Sold 220.0K
Granted 70.6K · Bought 5.0K · Sold 45.0K
Granted 36.4K · Bought 5.8K · Sold 12.9K
Granted 44.6K · Sold 5.3K
Granted 19.6K · Bought 5.4K
Granted 64.8K · Sold 38.9K
Granted 70.6K · Bought 5.5K · Sold 53.0K
Granted 40.0K · Sold 7.3K
Granted 37.0K · Sold 19.5K
Granted 43.8K · Sold 20.0K
Granted 70.8K · Sold 56.3K
Granted 98.7K · Sold 78.3K
Granted 49.1K · Sold 13.9K
Granted 62.8K · Sold 31.4K
Granted 101.5K · Sold 81.1K
Granted 19.2K
Granted 243.5K · Bought 23.2K · Sold 246.8K
Granted 24.0K · Bought 20.0K · Sold 28.0K
Granted 15.8K · Bought 100
Granted 122.0K · Bought 2.5K · Sold 101.0K
Granted 9.4K · Sold 6.4K
Granted 36.3K · Sold 25.5K
Granted 6.9K · Bought 3.5K
Granted 13.5K · Sold 1.7K
Granted 5.3K · Bought 3.8K
Granted 14.1K · Sold 2.4K
Granted 5.3K · Bought 2.5K
Granted 11.7K · Bought 1 · Sold 6.2K
Granted 8.6K · Sold 2.6K
Granted 6.3K · Sold 797
Granted 4.6K
Granted 6.7K · Sold 2.3K
Granted 4.0K
Granted 7.5K · Sold 3.7K
Granted 2.3K
Granted 2.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Prism Investment Partners III LP10% owner · 6 transactions | — | 3.57Mas of May 2007 | — | — | — |
| Brooks John L10% owner · 6 transactions | — | 3.50Mas of May 2007 | — | — | — |
| Prism Venture Partners III LLC10% owner · 6 transactions | — | 3.50Mas of May 2007 | — | — | — |
| Seifert William M10% owner · 6 transactions | — | 3.50Mas of May 2007 | — | — | — |
| Peyromaure de Bord AlisonDirector · 2 transactions | — | 2.90Mas of Nov 2007 | — | — | 511.1K |
| Brooks John L +4 co-filers10% owner · 1 transaction | — | 2.57Mas of Nov 2007 | — | — | 1.01M |
| Pequot Capital Management IncSee Footnote 1 · 1 transaction | — | 2.13Mas of May 2007 | — | — | — |
| Atwood Brian G +9 co-filersFormer 10% Owner, Former 10% Holder · 4 transactions | — | 2.13Mas of May 2007 | — | — | — |
| Colella Samuel DFormer 10% Owner · 4 transactions | — | 2.13Mas of May 2007 | — | — | — |
| Orbimed Advisors LLCDirector · 1 transaction | — | 1.57Mas of May 2007 | — | — | — |
| Silverstein JonathanDirector · 1 transaction | — | 1.57Mas of May 2007 | — | — | — |
| Jaffe Ross A MDDirector · 23 transactions | — | 1.34Mas of Feb 2012 | 8.0K | — | 807.4K |
| Sullivan Patrick JCEO and Chairman of the Board, Director · 20 transactions | — | 351.1Kas of Apr 2018 | 267.7K | 125.0K | — |
| DeSisto DuanePresident and CEO, Director · 195 transactions | — | 277.2Kas of Sep 2014 | 1.11M | — | 792.5K |
| Malave LuisChief Operating Officer · 57 transactions | — | 195.9Kas of Mar 2010 | 241.4K | — | 45.5K |
| Roberts Brian KChief Financial Officer · 42 transactions | — | 120.0Kas of Apr 2014 | 301.0K | — | 150.0K |
| Liamos Charles TDirector · 63 transactions | — | 87.6Kas of Apr 2015 | 431.8K | 8.0K | 282.8K |
| Petrovic ShaceyDirector · 114 transactions | — | 82.5Kas of Feb 2024 | 477.0K | — | 246.9K |
| Brooks John L +4 co-filers10% owner · 1 transaction | — | 79.0Kas of Nov 2007 | — | — | 31.0K |
| Gvazdauskas ShawnaVice President of Sales · 109 transactions | — | 73.9Kas of Dec 2007 | 80.0K | — | 80.0K |
| Prism Venture Partners III A LP10% owner · 6 transactions | — | 73.9Kas of May 2007 | — | — | — |
| Eichhorn GaryDirector · 3 transactions | — | 70.7Kas of Apr 2009 | 10.7K | 20.0K | — |
| Devlin PeterChief Commercial Officer · 25 transactions | — | 67.4Kas of Jun 2014 | 285.8K | — | 192.3K |
| Thomas Bradley AEVP Human Resources · 26 transactions | — | 65.8Kas of Mar 2018 | 77.9K | 12.6K | 10.8K |
| Campbell RobertVice President for Clinical · 18 transactions | — | 62.5Kas of Jan 2010 | 36.6K | 8.0K | 4.0K |
| Hollingshead JamesFormer President and CEO · 16 transactions | — | 61.2Kas of Apr 2025 | 89.1K | 5.5K | — |
| Alpuche CharlesAdvisor · 55 transactions | — | 58.2Kas of Mar 2023 | 145.8K | 9.1K | 60.0K |
| Levitz Michael LSVP and CFO · 14 transactions | — | 56.7Kas of Feb 2019 | 75.8K | — | 1.4K |
| Ryan PatrickChief Operating Officer · 4 transactions | — | 48.0Kas of May 2015 | 47.3K | 3.7K | — |
| Minogue Michael RDirector · 30 transactions | — | 47.0K | 14.6K | 5.3K | — |
| Colleran DavidSVP, Secretary and GC · 27 transactions | — | 37.8Kas of Apr 2019 | 72.0K | — | 51.1K |
| Dorval AllisonChief Financial Officer · 5 transactions | — | 37.4Kas of Apr 2015 | 17.8K | — | — |
| Scannell Timothy JDirector · 21 transactions | — | 33.0K | 44.8K | 3.5K | 15.3K |
| Wielinski Tracey HaasVP, Global Regulatory, CA, QA · 4 transactions | — | 32.3Kas of Mar 2014 | 14.0K | — | 8.3K |
| Diehl R AnthonySecretary and General Counsel · 104 transactions | — | 30.8Kas of May 2015 | 281.0K | — | 220.0K |
| Zakrzewski Joseph SDirector · 19 transactions | — | 30.6Kas of May 2017 | 70.6K | 5.0K | 45.0K |
| Hopfield JessicaDirector · 18 transactions | — | 29.4K | 36.4K | 5.8K | 12.9K |
| Kapples John W.SVP and General Counsel · 36 transactions | — | 27.5K | 44.6K | — | 5.3K |
| McEvoy AshleyPresident and CEO, Director · 5 transactions | — | 23.7K | 19.6K | 5.4K | — |
| Benjamin EricEVP and COO · 57 transactions | — | 23.6K | 64.8K | — | 38.9K |
| Sommer Regina ODirector · 20 transactions | — | 23.0Kas of May 2017 | 70.6K | 5.5K | 53.0K |
| McMillan Wayde D.EVP, CFO · 30 transactions | — | 21.5Kas of Jul 2023 | 40.0K | — | 7.3K |
| Schmid KevinVice President Manufacturing · 36 transactions | — | 21.3Kas of Mar 2008 | 37.0K | — | 19.5K |
| Levangie Daniel JEVP & President, Drug Delivery · 12 transactions | — | 21.1Kas of Apr 2016 | 43.8K | — | 20.0K |
| Fallon John A.Director · 29 transactions | — | 20.3Kas of May 2021 | 70.8K | — | 56.3K |
| Crawford SallyDirector · 28 transactions | — | 20.3Kas of Jun 2021 | 98.7K | — | 78.3K |
| Christensen BretEVP and CCO · 34 transactions | — | 20.2Kas of Feb 2023 | 49.1K | — | 13.9K |
| Abdel-Malek AimanEVP & Chief Technology Officer · 25 transactions | — | 19.7Kas of Mar 2019 | 62.8K | — | 31.4K |
| DePietro RuthannVice President of Quality · 90 transactions | — | 19.4Kas of Sep 2012 | 101.5K | — | 81.1K |
| Pease FlaviaEVP & CFO · 5 transactions | — | 19.2K | 19.2K | — | — |
| Boess CarstenVice President, International · 101 transactions | — | 18.9Kas of Apr 2011 | 243.5K | 23.2K | 246.8K |
| Sobieski StevenDirector · 9 transactions | — | 16.0Kas of May 2015 | 24.0K | 20.0K | 28.0K |
| Chadwick Ana MariaEVP, CFO & Treasurer · 4 transactions | — | 14.3Kas of May 2025 | 15.8K | 100 | — |
| Spears Michael PAdvisor · 76 transactions | — | 13.6Kas of Mar 2023 | 122.0K | 2.5K | 101.0K |
| Field Mark NSVP & Chief Technology Officer · 15 transactions | — | 13.4Kas of Feb 2025 | 9.4K | — | 6.4K |
| Lemoine David ADirector · 22 transactions | — | 10.8Kas of Nov 2021 | 36.3K | — | 25.5K |
| Weatherman Elizabeth HDirector · 7 transactions | — | 10.4K | 6.9K | 3.5K | — |
| Manea DanSVP, Chief HR Officer · 25 transactions | — | 9.1Kas of Jun 2025 | 13.5K | — | 1.7K |
| Stonesifer Timothy C.Director · 6 transactions | — | 9.0K | 5.3K | 3.8K | — |
| Budden LaurenGroup VP, CAO and Controller · 38 transactions | — | 8.6K | 14.1K | — | 2.4K |
| Mullen James CDirector · 3 transactions | — | 7.8Kas of May 2018 | 5.3K | 2.5K | — |
| Singh PremSVP, Global Operations · 23 transactions | — | 7.0K | 11.7K | 1 | 6.2K |
| Nevinny Corinne HDirector · 9 transactions | — | 6.0Kas of May 2023 | 8.6K | — | 2.6K |
| Cousin LaetitiaSVP, Reg, Quality & Compliance · 17 transactions | — | 5.7K | 6.3K | — | 797 |
| Davis Lisa BlairSVP, Chief HR Officer · 2 transactions | — | 4.6K | 4.6K | — | — |
| Borio LucianaDirector · 12 transactions | — | 4.3K | 6.7K | — | 2.3K |
| Lortz W MarkDirector · 1 transaction | — | 4.0Kas of Jun 2013 | 4.0K | — | — |
| Frederick Wayne A.I.Director · 9 transactions | — | 3.8K | 7.5K | — | 3.7K |
| Huffines Robert LutherDirector · 4 transactions | — | 2.3K | 2.3K | — | — |
| Prism Venture Partners III A LP +3 co-filers10% owner · 1 transaction | — | 1.2Kas of Feb 2008 | — | — | — |
| Panos MichaelEVP and CCO · 1 transaction | — | 5 | 2.8K | — | — |
| Prism Venture Partners III LP10% owner · 7 transactions | — | 0as of Feb 2008 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -5.13M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.